Bloomberg News

Novozymes Third-Quarter Profit Beats Most Analyst Estimates

October 28, 2011

Oct. 28 (Bloomberg) -- Novozymes A/S, the world’s largest maker of industrial enzymes, reported third-quarter net income of 518 million kroner, beating the 460 million-krone average estimate in a Bloomberg survey of nine analysts.

Novozymes had net income of 439 million kroner in the third quarter of 2010. The Bagsvaerd, Denmark-based company published its earnings report in stock-exchange statement today.

Novozymes also raised the bottom end of its full-year net profit growth forecast range. The company said it now expects net profit growth of 11 percent to 13 percent compared with 10 percent to 13 percent previously.

To contact the editor responsible for this story: Christian Wienberg at

The Aging of Abercrombie & Fitch
blog comments powered by Disqus